{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:40:10Z","timestamp":1795034410236,"version":"4.10.2"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-019040"],"award-info":[{"award-number":["MJFF-019040"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS119689"],"award-info":[{"award-number":["R01NS119689"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS119689"],"award-info":[{"award-number":["R01NS119689"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66146-4","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:51:03Z","timestamp":1765381863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates"],"prefix":"10.1038","volume":"16","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-3362","authenticated-orcid":false,"given":"Victor","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9513-8554","authenticated-orcid":false,"given":"Tyler","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8056-3038","authenticated-orcid":false,"given":"Danielle","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Al-Lahham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4433-9407","authenticated-orcid":false,"given":"Nicole","family":"De Gregorio Carbonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Kaalund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0940-3098","authenticated-orcid":false,"given":"Jonas","family":"Folke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-8389","authenticated-orcid":false,"given":"Luis","family":"Concha-Marambio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Ishtikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata KPS","family":"Mallampalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pritzkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahnawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-8523","authenticated-orcid":false,"given":"Matthew L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Serysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3412-0524","authenticated-orcid":false,"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"66146_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"66146_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(05)79256-4","volume":"352","author":"WP Gai","year":"1998","unstructured":"Gai, W. P., Power, J. H., Blumbergs, P. C. & Blessing, W. W. Multiple-system atrophy: A new alpha-synuclein disease?. Lancet 352, 547\u2013548 (1998).","journal-title":"Lancet"},{"key":"66146_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"66146_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1385\/JMN:17:2:225","volume":"17","author":"PT Kotzbauer","year":"2001","unstructured":"Kotzbauer, P. T., Trojanowsk, J. Q. & Lee, V. M. Lewy body pathology in Alzheimer\u2019s disease. J. Mol. Neurosci. 17, 225\u2013232 (2001).","journal-title":"J. Mol. Neurosci."},{"key":"66146_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga, S., Sekiya, H., Kondru, N., Ross, O. A. & Dickson, D. W. Neuropathology and molecular diagnosis of Synucleinopathies. Mol. Neurodegener. 16, 83 (2021).","journal-title":"Mol. Neurodegener."},{"key":"66146_CR6","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/brain\/awaf030","volume":"148","author":"JA Wiseman","year":"2025","unstructured":"Wiseman, J. A., Halliday, G. M. & Dieriks, B. V. Neuronal alpha-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy. Brain 148, 2306\u20132319 (2025).","journal-title":"Brain"},{"key":"66146_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557, 558\u2013563 (2018).","journal-title":"Nature"},{"key":"66146_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren, A. et al. The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol. 139, 977\u20131000 (2020).","journal-title":"Acta Neuropathol."},{"key":"66146_CR9","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner, S. B. et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with Parkinsonism. Proc. Natl. Acad. Sci. USA 112, E5308\u2013E5317 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66146_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332\u20131340 (2018).","journal-title":"Nat. Neurosci."},{"key":"66146_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng, C., Gathagan, R. J. & Lee, V. M. Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies. Neurobiol. Dis. 109, 209\u2013218 (2018).","journal-title":"Neurobiol. Dis."},{"key":"66146_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"66146_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak, H., Rub, U., Gai, W. P. & Del Tredici, K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110, 517\u2013536 (2003).","journal-title":"J. Neural Transm."},{"key":"66146_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med. 14, 501\u2013503 (2008).","journal-title":"Nat. Med."},{"key":"66146_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat. Med. 14, 504\u2013506 (2008).","journal-title":"Nat. Med."},{"key":"66146_CR16","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert, M. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 349, 1255555 (2015).","journal-title":"Science"},{"key":"66146_CR17","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1073\/pnas.0536383100","volume":"100","author":"D Kirik","year":"2003","unstructured":"Kirik, D. et al. Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 100, 2884\u20132889 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66146_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"66146_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med."},{"key":"66146_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens, A. et al. Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. 75, 351\u2013362 (2014).","journal-title":"Ann. Neurol."},{"key":"66146_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki, T. R. et al. Parkinson\u2019s disease and multiple system atrophy have distinct alpha-synuclein seed characteristics. J. Biol. Chem. 294, 1045\u20131058 (2019).","journal-title":"J. Biol. Chem."},{"key":"66146_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9165","volume":"6","author":"M Bourdenx","year":"2020","unstructured":"Bourdenx, M. et al. Identification of distinct pathological signatures induced by patient-derived alpha-synuclein structures in nonhuman primates. Sci. Adv. 6, eaaz9165 (2020).","journal-title":"Sci. Adv."},{"key":"66146_CR23","doi-asserted-by":"publisher","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts, J. C. et al. Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. USA 110, 19555\u201319560 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66146_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Structures of alpha-synuclein filaments from human brains with Lewy pathology. Nature 610, 791\u2013795 (2022).","journal-title":"Nature"},{"key":"66146_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser, M. et al. Structures of alpha-synuclein filaments from multiple system atrophy. Nature 585, 464\u2013469 (2020).","journal-title":"Nature"},{"key":"66146_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz, M. et al. Development of a biochemical diagnosis of parkinson disease by detection of alpha-Synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 74, 163\u2013172 (2017).","journal-title":"JAMA Neurol."},{"key":"66146_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz, M. et al. Discriminating alpha-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578, 273\u2013277 (2020).","journal-title":"Nature"},{"key":"66146_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio, L., Pritzkow, S., Shahnawaz, M., Farris, C. M. & Soto, C. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat. Protoc. 18, 1179\u20131196 (2023).","journal-title":"Nat. Protoc."},{"key":"66146_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.tibtech.2024.01.007","volume":"42","author":"C Soto","year":"2024","unstructured":"Soto, C. alpha-Synuclein seed amplification technology for Parkinson\u2019s disease and related synucleinopathies. Trends Biotechnol. 42, 829\u2013841 (2024).","journal-title":"Trends Biotechnol."},{"key":"66146_CR30","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz, M. et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat. Protoc. 11, 2233\u20132242 (2016).","journal-title":"Nat. Protoc."},{"key":"66146_CR31","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810\u2013813 (2001).","journal-title":"Nature"},{"key":"66146_CR32","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul, G. et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 3, 812\u2013818 (2016).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"66146_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman, B. R. et al. Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC. Acta Neuropathol. Commun. 6, 7 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"66146_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mds.27646","volume":"34","author":"UJ Kang","year":"2019","unstructured":"Kang, U. J. et al. Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson\u2019s disease. Mov. Disord. 34, 536\u2013544 (2019).","journal-title":"Mov. Disord."},{"key":"66146_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca, C. M. G. et al. Efficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl. Neurodegener. 8, 24 (2019).","journal-title":"Transl. Neurodegener."},{"key":"66146_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2019.05.002","volume":"129","author":"A Fenyi","year":"2019","unstructured":"Fenyi, A. et al. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification. Neurobiol. Dis. 129, 38\u201343 (2019).","journal-title":"Neurobiol. Dis."},{"key":"66146_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49\u201362 (2020).","journal-title":"Acta Neuropathol."},{"key":"66146_CR38","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.28242","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne, S. et al. Blinded RT-QuIC Analysis of alpha-Synuclein Biomarker in Skin Tissue From Parkinson\u2019s Disease Patients. Mov. Disord. 35, 2230\u20132239 (2020).","journal-title":"Mov. Disord."},{"key":"66146_CR39","first-page":"1","volume":"78","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Skin alpha-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol. 78, 1\u201311 (2020).","journal-title":"JAMA Neurol."},{"key":"66146_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-021-01175-w","volume":"9","author":"C Bargar","year":"2021","unstructured":"Bargar, C. et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol. Commun. 9, 62 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"66146_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo, M. J. et al. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol. Commun. 9, 179 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"66146_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"66146_CR43","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","volume":"23","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Lancet Neurol. 23, 1225\u20131237 (2024).","journal-title":"Lancet Neurol."},{"key":"66146_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36402","volume":"7","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira, R. et al. Cryo-EM structure of alpha-synuclein fibrils. Elife 7, e36402 (2018).","journal-title":"Elife"},{"key":"66146_CR45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48907","volume":"8","author":"R Guerrero-Ferreira","year":"2019","unstructured":"Guerrero-Ferreira, R. et al. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. Elife 8, e48907 (2019).","journal-title":"Elife"},{"key":"66146_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat. Struct. Mol. Biol. 23, 409\u2013415 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66146_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.19046","volume":"12","author":"HK Chung","year":"2019","unstructured":"Chung, H. K., Ho, H. A., Perez-Acuna, D. & Lee, S. J. Modeling alpha-Synuclein propagation with preformed fibril injections. J. Mov. Disord. 12, 139\u2013151 (2019).","journal-title":"J. Mov. Disord."},{"key":"66146_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"66146_CR49","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA 106, 20051\u201320056 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66146_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jnen\/nlz070","volume":"78","author":"N Uemura","year":"2019","unstructured":"Uemura, N. et al. Slow progressive accumulation of oligodendroglial Alpha-Synuclein (alpha-Syn) pathology in synthetic alpha-syn fibril-induced mouse models of synucleinopathy. J. Neuropathol. Exp. Neurol. 78, 877\u2013890 (2019).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"66146_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset, L. et al. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575 (2013).","journal-title":"Nat. Commun."},{"key":"66146_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-019-0733-3","volume":"7","author":"JS Dhillon","year":"2019","unstructured":"Dhillon, J. S. et al. Comparative analyses of the in vivo induction and transmission of alpha-synuclein pathology in transgenic mice by MSA brain lysate and recombinant alpha-synuclein fibrils. Acta Neuropathol. Commun. 7, 80 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"66146_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau, A. et al. alpha-Synuclein strains target distinct brain regions and cell types. Nat. Neurosci. 23, 21\u201331 (2020).","journal-title":"Nat. Neurosci."},{"key":"66146_CR54","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40478-021-01288-2","volume":"9","author":"NP Marotta","year":"2021","unstructured":"Marotta, N. P. et al. Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro. Acta Neuropathol. Commun. 9, 188 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"66146_CR55","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy. Cell Res 28, 897\u2013903 (2018).","journal-title":"Cell Res"},{"key":"66146_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Strohaker","year":"2019","unstructured":"Strohaker, T. et al. Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts. Nat. Commun. 10, 5535 (2019).","journal-title":"Nat. Commun."},{"key":"66146_CR57","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41589-022-01229-7","volume":"19","author":"SW Manka","year":"2023","unstructured":"Manka, S. W. et al. A structural basis for prion strain diversity. Nat. Chem. Biol. 19, 607\u2013613 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"66146_CR58","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930\u2013936 (2007).","journal-title":"Science"},{"key":"66146_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrm2204","volume":"8","author":"A Aguzzi","year":"2007","unstructured":"Aguzzi, A., Heikenwalder, M. & Polymenidou, M. Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 8, 552\u2013561 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"66146_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/128_2011_166","volume":"305","author":"GC Telling","year":"2011","unstructured":"Telling, G. C. Transgenic mouse models and prion strains. Top. Curr. Chem. 305, 79\u201399 (2011).","journal-title":"Top. Curr. Chem."},{"key":"66146_CR61","doi-asserted-by":"publisher","first-page":"a024349","DOI":"10.1101\/cshperspect.a024349","volume":"6","author":"JC Bartz","year":"2016","unstructured":"Bartz, J. C. Prion Strain Diversity. Cold Spring Harb. Perspect. Med 6, a024349 (2016).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"66146_CR62","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1038\/emboj.2008.181","volume":"27","author":"J Castilla","year":"2008","unstructured":"Castilla, J. et al. Cell-free propagation of prion strains. EMBO J. 27, 2557\u20132566 (2008).","journal-title":"EMBO J."},{"key":"66146_CR63","doi-asserted-by":"publisher","first-page":"13439","DOI":"10.1128\/JVI.06134-11","volume":"85","author":"RA Shikiya","year":"2011","unstructured":"Shikiya, R. A. & Bartz, J. C. In vitro generation of high-titer prions. J. Virol. 85, 13439\u201313442 (2011).","journal-title":"J. Virol."},{"key":"66146_CR64","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson, B. I. et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34, 521\u2013533 (2002).","journal-title":"Neuron"},{"key":"66146_CR65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-015-1442-z","volume":"130","author":"N Aoki","year":"2015","unstructured":"Aoki, N. et al. Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein. Acta Neuropathol. 130, 93\u2013105 (2015).","journal-title":"Acta Neuropathol."},{"key":"66146_CR66","doi-asserted-by":"publisher","first-page":"168011","DOI":"10.1016\/j.jmb.2023.168011","volume":"435","author":"RWL So","year":"2023","unstructured":"So, R. W. L. & Watts, J. C. alpha-Synuclein conformational strains as drivers of phenotypic heterogeneity in neurodegenerative diseases. J. Mol. Biol. 435, 168011 (2023).","journal-title":"J. Mol. Biol."},{"key":"66146_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","volume":"142","author":"SAM Holec","year":"2021","unstructured":"Holec, S. A. M. & Woerman, A. L. Evidence of distinct alpha-synuclein strains underlying disease heterogeneity. Acta Neuropathol. 142, 73\u201386 (2021).","journal-title":"Acta Neuropathol."},{"key":"66146_CR68","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-021-02312-4","volume":"141","author":"A Thomzig","year":"2021","unstructured":"Thomzig, A. et al. Transmissible alpha-synuclein seeding activity in brain and stomach of patients with Parkinson\u2019s disease. Acta Neuropathol. 141, 861\u2013879 (2021).","journal-title":"Acta Neuropathol."},{"key":"66146_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40035-024-00456-3","volume":"13","author":"JA Wiseman","year":"2024","unstructured":"Wiseman, J. A. et al. N-terminus alpha-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson\u2019s disease. Transl. Neurodegener. 13, 67 (2024).","journal-title":"Transl. Neurodegener."},{"key":"66146_CR70","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/2211-5463.13110","volume":"11","author":"S Lovestam","year":"2021","unstructured":"Lovestam, S. et al. Seeded assembly in vitro does not replicate the structures of alpha-synuclein filaments from multiple system atrophy. FEBS Open Bio 11, 999\u20131013 (2021).","journal-title":"FEBS Open Bio"},{"key":"66146_CR71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"66146_CR72","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Novel tau filament fold in corticobasal degeneration. Nature 580, 283\u2013287 (2020).","journal-title":"Nature"},{"key":"66146_CR73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359\u2013363 (2021).","journal-title":"Nature"},{"key":"66146_CR74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.pmbts.2020.07.009","volume":"175","author":"S Supattapone","year":"2020","unstructured":"Supattapone, S. Cofactor molecules: Essential partners for infectious prions. Prog. Mol. Biol. Transl. Sci. 175, 53\u201375 (2020).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"66146_CR75","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1073\/pnas.1601899113","volume":"113","author":"C Galvagnion","year":"2016","unstructured":"Galvagnion, C. et al. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of alpha-synuclein. Proc. Natl. Acad. Sci. USA 113, 7065\u20137070 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66146_CR76","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1021\/acs.jpcb.1c01281","volume":"125","author":"STA Amos","year":"2021","unstructured":"Amos, S. T. A. et al. Membrane Interactions of alpha-Synuclein revealed by multiscale molecular dynamics simulations, Markov state models, and NMR. J. Phys. Chem. B 125, 2929\u20132941 (2021).","journal-title":"J. Phys. Chem. B"},{"key":"66146_CR77","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/acs.biochem.2c00207","volume":"61","author":"CH Tran","year":"2022","unstructured":"Tran, C. H., Saha, R., Blanco, C., Bagchi, D. & Chen, I. A. Modulation of alpha-Synuclein aggregation in vitro by a DNA aptamer. Biochemistry 61, 1757\u20131765 (2022).","journal-title":"Biochemistry"},{"key":"66146_CR78","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/acschemneuro.6b00227","volume":"7","author":"V Banerjee","year":"2016","unstructured":"Banerjee, V. et al. Superoxide dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants. ACS Chem. Neurosci. 7, 1595\u20131606 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"66146_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1107\/S2059798319016577","volume":"76","author":"SHW Scheres","year":"2020","unstructured":"Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D Struct. Biol. 76, 94\u2013101 (2020).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"66146_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsb.2017.02.003","volume":"198","author":"S He","year":"2017","unstructured":"He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163\u2013176 (2017).","journal-title":"J. Struct. Biol."},{"key":"66146_CR81","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).","journal-title":"Elife"},{"key":"66146_CR82","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"66146_CR83","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"66146_CR84","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jsb.2010.03.007","volume":"170","author":"GD Pintilie","year":"2010","unstructured":"Pintilie, G. D., Zhang, J., Goddard, T. D., Chiu, W. & Gossard, D. C. Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. J. Struct. Biol. 170, 427\u2013438 (2010).","journal-title":"J. Struct. Biol."},{"key":"66146_CR85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jsb.2016.06.004","volume":"196","author":"M Chen","year":"2016","unstructured":"Chen, M., Baldwin, P. R., Ludtke, S. J. & Baker, M. L. De Novo modeling in cryo-EM density maps with Pathwalking. J. Struct. Biol. 196, 289\u2013298 (2016).","journal-title":"J. Struct. Biol."},{"key":"66146_CR86","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"66146_CR87","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66146-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:02:52Z","timestamp":1766188972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66146-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66146"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66146-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Claudio Soto is a Founder, Chief Scientific Officer, consultant and shareholder of Amprion Inc., a biotechnology company that focuses on the commercial use of seed amplification assays for high-sensitivity detection of misfolded protein aggregates involved in various neurodegenerative diseases. Luis Concha is an employee of Amprion Inc. and Sandra Pritzkow also has a conflict in relation to Amprion. The University of Texas Health Science Center at Houston has licensed patents and patent applications to Amprion. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11266"}}